Cargando…

In Silico Establishment and Validation of Novel Lipid Metabolism-Related Gene Signature in Bladder Cancer

BACKGROUND: Aberrant lipid metabolism is an alteration common to many types of cancer. Dysregulation of lipid metabolism is considered a major risk factor for bladder cancer. Accordingly, we focused on genes related to lipid metabolism and screened novel markers for predicting the prognosis of bladd...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Xianchao, Zhang, Ying, Chen, Yilai, Xin, Shiyong, Jin, Liang, Liu, Xiang, Zhou, Zhen, Zhang, Jiaxin, Mei, Wangli, Zhang, Bihui, Yao, Xudong, Yang, Guosheng, Ye, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038413/ https://www.ncbi.nlm.nih.gov/pubmed/35480865 http://dx.doi.org/10.1155/2022/3170950

Ejemplares similares

Identification and validation of a hypoxia-related prognostic and immune microenvironment signature in bladder cancer
por: Sun, Xianchao, et al.
Publicado: (2021)

A Cuproptosis-Related Gene Model For Predicting the Prognosis of Clear Cell Renal Cell Carcinoma
por: Mei, Wangli, et al.
Publicado: (2022)

A N(7)-Methylguanine-Related Gene Signature Applicable for the Prognosis and Microenvironment of Prostate Cancer
por: Mei, Wangli, et al.
Publicado: (2022)

Computer classification and construction of a novel prognostic signature based on moonlighting genes in prostate cancer
por: Mei, Wangli, et al.
Publicado: (2022)

Identifying the Potential Role and Prognostic Value of the Platelet-Derived Growth Factor Pathway in Kidney Renal Clear Cell Carcinoma
por: Xin, Shiyong, et al.
Publicado: (2022)

Long non-coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathway
por: Sun, Xianchao, et al.
Publicado: (2022)

Identification of cuproptosis -related subtypes, the development of a prognosis model, and characterization of tumor microenvironment infiltration in prostate cancer
por: Jin, Liang, et al.
Publicado: (2022)

Ubiquitin-related lncRNAs: The new tool for prognosis prediction in prostate cancer
por: Liu, Xiang, et al.
Publicado: (2022)

Neurexophilin 4 is a prognostic biomarker correlated with immune infiltration in bladder cancer
por: Sun, Xianchao, et al.
Publicado: (2022)

Discovery of Notch Pathway-Related Genes for Predicting Prognosis and Tumor Microenvironment Status in Bladder Cancer
por: Sun, Xianchao, et al.
Publicado: (2022)

The Prognostic Signature and Therapeutic Value of Phagocytic Regulatory Factors in Prostate Adenocarcinoma (PRAD)
por: Xin, Shiyong, et al.
Publicado: (2022)

Discovery of Lipid Metabolism-Related Genes for Predicting Tumor Immune Microenvironment Status and Prognosis in Prostate Cancer
por: Zhang, Ying, et al.
Publicado: (2022)

ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer
por: Xin, Shiyong, et al.
Publicado: (2023)

In silico development and validation of a novel glucose and lipid metabolism-related gene signature in gastric cancer
por: Yang, Yuan, et al.
Publicado: (2022)

Construction and Validation of a Novel Eight-Gene Risk Signature to Predict the Progression and Prognosis of Bladder Cancer
por: Wang, Ruiliang, et al.
Publicado: (2021)

Establishing and validating an ADCP-related prognostic signature in pancreatic ductal adenocarcinoma
por: Zhang, Deyu, et al.
Publicado: (2022)

In silico analysis of the immune microenvironment in bladder cancer
por: Zhang, Ye, et al.
Publicado: (2020)

Identification and validation of an 18-gene signature highly-predictive of bladder cancer metastasis
por: Wang, Beihe, et al.
Publicado: (2018)

Establishment and validation of a novel immune-related prognostic signature in malignant pleural mesothelioma
por: Zhang, Xiangxin, et al.
Publicado: (2022)

Establishment and Validation of a Prognostic Immune Signature in Neuroblastoma
por: Yu, Yunhu, et al.
Publicado: (2021)

Establishing and Validating an Aging-Related Prognostic Signature in Osteosarcoma
por: Ma, Yibo, et al.
Publicado: (2023)

Establishment and validation of a 7-microRNA prognostic signature for non-small cell lung cancer
por: Wang, Nan, et al.
Publicado: (2018)

Establishment and Validation of an Individualized Cell Cycle Process-Related Gene Signature to Predict Cancer-Specific Survival in Patients with Bladder Cancer
por: Shi, Run, et al.
Publicado: (2020)

Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism‐related genes
por: Wang, Zhihao, et al.
Publicado: (2021)

Animal models for bladder cancer: The model establishment and evaluation (Review)
por: ZHANG, NING, et al.
Publicado: (2015)

Identification and validation of a prognostic immune-related lncRNA signature in bladder cancer
por: Zhao, Kai, et al.
Publicado: (2021)

Establishment and validation of serum lipid-based nomogram for predicting the risk of prostate cancer
por: Feng, Fu, et al.
Publicado: (2023)

Establishment and Validation of a Ferroptosis-Related Gene Signature to Predict Overall Survival in Lung Adenocarcinoma
por: Wang, Su, et al.
Publicado: (2022)

In silico development and experimental validation of a novel 7-gene signature based on PI3K pathway-related genes in bladder cancer
por: Wang, Linhui, et al.
Publicado: (2022)

Validation and clinicopathologic associations of a urine-based bladder cancer biomarker signature
por: Zhang, Ge, et al.
Publicado: (2014)

Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer
por: Zhu, Ke, et al.
Publicado: (2021)

Development of Simple and Accurate in Silico Ligand-Based Models for Predicting ABCG2 Inhibition
por: Huang, Shuheng, et al.
Publicado: (2022)

Identification and validation of an immune signature associated with EMT and metabolic reprogramming for predicting prognosis and drug response in bladder cancer
por: Zhang, Zhao, et al.
Publicado: (2022)

Identification and Validation of an Annexin-Related Prognostic Signature and Therapeutic Targets for Bladder Cancer: Integrative Analysis
por: Yao, Xitong, et al.
Publicado: (2022)

Identification and validation of a novel signature for prediction the prognosis and immunotherapy benefit in bladder cancer
por: Zhang, Yichi, et al.
Publicado: (2022)

Establishment and validation of a ferroptosis-related prognostic signature for hepatocellular carcinoma
por: He, Yixian, et al.
Publicado: (2023)

Establishment and validation of a predictive model of preeclampsia based on transcriptional signatures of 43 genes in decidua basalis and peripheral blood
por: Zhang, Hongya, et al.
Publicado: (2022)

A New Method of Establishing Orthotopic Bladder Transplantable Tumor in Mice
por: Yang, Xi-hua, et al.
Publicado: (2012)

Development and Validation of a Six-Gene Prognostic Signature for Bladder Cancer
por: Xu, Fei, et al.
Publicado: (2021)

m7G-Associated subtypes, tumor microenvironment, and validation of prognostic signature in lung adenocarcinoma
por: Wang, Guangyao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n9eia8iu8slh2v2pn831phd0nb